Maribavir clinical trials

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

This study is looking at a new medicine called maribavir for children and teenagers who have had an organ or stem cell transplant and have a cytomegalovirus (CMV) infection. We want to check if it's safe, how well it works, and find the best dose.